Read E.V.I.dently Today for current news about health policy and events, among other topics.
E.V.I.dently Today Blog
The Medicare Trustees Annual Report issued last week was a mix of positive news and a stark reminder that we need to find thoughtful solutions to ensure that the Medicare program will remain solvent for a long time to come.
Patients who have the same condition sometimes pay different out-of-pocket costs for their medications, but when is this differential more appropriate? Join NPC in tackling this dilemma in the webinar “Same Condition, Different Costs: Should Patients Pay Different Amounts?” on Tuesday, July 18, from 12 p.m.-1 p.m. Eastern Time.
NPC expressed concerns about the partnership between the Institute for Clinical and Economic Review and the U.S. Department of Veterans Affairs Pharmacy Benefits Management Services office to integrate ICER’s value assessment framework in the VA’s formulary management process.
A feature article in this month's Value and Outcomes Spotlight highlights the importance of comparative effectiveness research (CER) and details the CER Collaborative Initiative, a joint effort by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the Academy of Managed Care Pharmacy (AMCP) and the National Pharmaceutical Council (NPC) to assist health care decision-makers in assessing and synthesizing these studies.
In his commentary for the American Journal of Pharmacy Benefits, NPC President Dan Leonard explores the challenges and opportunities in implementing value-based contracts.
The Institute for Clinical and Economic Review (ICER) today released its revised value assessment framework, which included a number of changes reflected in NPC's extensive public comments, but NPC remains concerned about several key provisions that ICER has not addressed.